Rib-X Pharmaceuticals, Inc.
Industry: Pharmaceuticals (See others in industry)
Address:
300 George Street Suite 301
New Haven, CT, 06511
Phone: 203-624-5606
New Haven, CT, 06511
Phone: 203-624-5606
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2012-11-30 | New | $18,686,500 | $18,686,500 | Equity Only | 06 | SEC link |
| 2011-01-28 | New | $5,500,000 | $5,500,000 | Debt Only | 06 | SEC link |
| 2010-06-10 | New | $5,500,000 | $5,500,000 | Debt Only | 06 | SEC link |
| 2007-10-12 | Paper Filing | Unknown | Unknown | Other | Not Available | |
| 2006-06-26 | Paper Filing | Unknown | Unknown | Other | Not Available |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| C. Boyd Clarke | Director |
| Robert Conerly | Executive |
| Jonathan Fleming | Director |
| Cecilia Gonzalo | Director |
| Peter Greenleaf | Director |
| Jonathan S. Leff | Director |
| Mark Leuchtenberger | Director, Executive |
| George Milne | Director |
| George M. Milne, Jr. | Director |
| Harry H. Penner, Jr. | Director |
| Raymond Whitaker | Director |